Corneal Lenticule Implantation in Keratoconus Disease With Relex Smile Surgery
1 other identifier
interventional
40
1 country
1
Brief Summary
CORNEAL LENTICULE IMPLANTATION IN KERATOCONUS DISEASE WITH RELEX SMILE SURGERY
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2018
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2019
CompletedFirst Submitted
Initial submission to the registry
June 15, 2020
CompletedFirst Posted
Study publicly available on registry
October 19, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 15, 2024
CompletedFebruary 20, 2024
February 1, 2024
1 year
June 15, 2020
February 15, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Increase of corneal thickness at patients Lenticule group
Increase of corneal central thickness using fresh lenticule with stromal stem cells and live keratocytes
12 months
Secondary Outcomes (1)
Improvement of visual acuity at patients Lenticule group
12 months
Study Arms (2)
Smile Group
ACTIVE COMPARATORTwenty patients (20) underwent SMILE surgery (first group)
Lenticule Group
ACTIVE COMPARATORTwenty patients (20) underwent lenticule implantation (second group)
Interventions
Lenticule Implantation in Keratoconus Disease with RELEX Smile Surgery using VisuMax Femtosecond laser- Smile module surgery with primary objective to increase central corneal thickness and secondary objective to improve visual acuity and reduces K-values
Eligibility Criteria
You may qualify if:
- Patients clinically diagnosed with progressive keratoconus
You may not qualify if:
- Active anterior segment pathologic features, Corneal thickness over 420, Previous corneal or anterior segment surgery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Dr. Faruk Semizlead
Study Sites (1)
Eye Hospital Pristina
Pristina, 10000, Kosovo
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Principal Doctor
Study Record Dates
First Submitted
June 15, 2020
First Posted
October 19, 2020
Study Start
January 1, 2018
Primary Completion
January 1, 2019
Study Completion
December 15, 2024
Last Updated
February 20, 2024
Record last verified: 2024-02
Data Sharing
- IPD Sharing
- Will not share